A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)
Public ClinicalTrials.gov record NCT05335122. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Multi-center, Randomized, Parallel-group, Controlled Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant in Subjects With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To assess efficacy, and safety of a single sustained release dose of the OTX-TIC drug product (2 travoprost dose strengths) in subjects with Open Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
Study identification
- NCT ID
- NCT05335122
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 83 participants
Conditions and interventions
Conditions
Interventions
- OTX-TIC low dose Travoprost Intracameral Implant Drug
- OTX-TIC high dose Travoprost Intracameral Implant Drug
- Durysta, Bimatoprost Intracameral Implant 10 µg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 16, 2022 (Actual)
- Primary completion
- Jan 24, 2024 (Actual)
- Completion
- Jan 24, 2025 (Actual)
- Last update posted
- Sep 3, 2026
2022 – 2025
United States locations
- U.S. sites
- 30
- U.S. states
- 17
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ocular Therapeutix, Inc. | Dothan | Alabama | 36301 | — |
| Ocular Therapeutix, Inc. | Huntington Beach | California | 92647 | — |
| Ocular Therapeutix, Inc. | Irvine | California | 92604 | — |
| Ocular Therapeutix, Inc. | Los Angeles | California | 90013 | — |
| Ocular Therapeutix, Inc. | Pasadena | California | 91107 | — |
| Ocular Therapeutix, Inc. | Petaluma | California | 94954 | — |
| Ocular Therapeutix, Inc. | Redlands | California | 92373 | — |
| Ocular Therapeutix, Inc. | Torrance | California | 90505 | — |
| Ocular Therapeutix, Inc. | Clearwater | Florida | 33761 | — |
| Ocular Therapeutiux, Inc. | Delray Beach | Florida | 33484 | — |
| Ocular Therapeutix, Inc. | Fort Myers | Florida | 33901 | — |
| Ocular Therapeutix, Inc. | Roswell | Georgia | 30076 | — |
| Ocular Therapeutix, Inc. | Rock Island | Illinois | 61201 | — |
| Ocular Therapeutix Inc | Carmel | Indiana | 46032 | — |
| Ocular Therapeutix, Inc. | Saint Joseph | Michigan | 49085 | — |
| Ocular Therapeutix, Inc. | Saint Joseph | Missouri | 49085 | — |
| Ocular Therapeutix Inc. | St Louis | Missouri | 63110 | — |
| Ocular Therapeutix, Inc. | Dover | New Jersey | 07801 | — |
| Ocular Therapeutix, Inc. | Troy | New York | 12108 | — |
| Ocular Therapeutix, Inc. | Durham | North Carolina | 27710 | — |
| Ocular Therapeutiux, Inc. | Fargo | North Dakota | 58103 | — |
| Ocular Therapeutix, Inc. | Cleveland | Ohio | 44106 | — |
| Ocular Therapeutix Inc | Oklahoma City | Oklahoma | 73112 | — |
| Ocular Therapeutix, Inc. | Cranberry Township | Pennsylvania | 16066 | — |
| Ocular Therapeutix, Inc. | Philadelphia | Pennsylvania | 19107 | — |
| Ocular Therapeutix, Inc. | Austin | Texas | 78701 | — |
| Ocular Therapeutix, Inc. | Dallas | Texas | 75231 | — |
| Ocular Therapeutix, Inc. | El Paso | Texas | 79902 | — |
| Ocular Therapeutix, Inc. | Houston | Texas | 77030 | — |
| Ocular Therapeutix, Inc. | Kenosha | Wisconsin | 53142 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05335122, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 3, 2026 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05335122 live on ClinicalTrials.gov.